-
Loading metrics
Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma
- Birgit Engesæter,
- Olav Engebraaten,
- Vivi Ann Flørenes,
- Gunhild Mari Mælandsmo
x
- Published: September 20, 2012
- https://doi.org/10.1371/journal.pone.0045492